1-4 of 4
cold hemagglutinin disease
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program

Clinical Trials & Observations
Georg Gelbenegger, Christian Schoergenhofer, Ulla Derhaschnig, Nina Buchtele, Christian Sillaber, Michael Fillitz, Thomas M. Schenk, Shirley D’Sa, Ronwyn Cartwright, James C. Gilbert, Bernd Jilma, Ulrich Jaeger
Journal: Blood Advances
Blood Adv (2020) 4 (6): 997–1005.
https://doi.org/10.1182/bloodadvances.2019001321
Published: 2020
Includes: Supplemental data
Journal Articles

Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial

Clinical Trials & Observations
Alexander Röth, Martin Bommer, Andreas Hüttmann, Dörte Herich-Terhürne, Nils Kuklik, Jan Rekowski, Veronika Lenz, Hubert Schrezenmeier, Ulrich Dührsen
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2543–2549.
https://doi.org/10.1182/bloodadvances.2018024190
Published: 2018
Journal Articles

Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab

Clinical Trials & Observations
Merve Hasanov, Sergej N. Konoplev, Cristhiam M. Rojas Hernandez
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1865–1868.
https://doi.org/10.1182/bloodadvances.2018019000
Published: 2018
Journal Articles

Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization

Clinical Trials & Observations
Megan Mullins, Xiaohui Jiang, Lauren C. Bylsma, Jon P. Fryzek, Heidi Reichert, Evan C. Chen, Shivaani Kummar, Adam Rosenthal
Journal: Blood Advances
Blood Adv (2017) 1 (13): 839–848.
https://doi.org/10.1182/bloodadvances.2017004390
Published: 2017
Includes: Supplemental data